Western Union Expands Global Real-Time Payments Network
23.4.2020 16:00:00 EEST | Business Wire | Press release
Western Union (NYSE: WU), a leader in cross-border, cross-currency money movement and payments, today announced continued expansion of its Global Network for real-time money-movement and payments, benefiting the Company’s consumers and clients across its branded money transfer and payments business as well as its expanding white-label business.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200423005498/en/
Western Union’s vast global retail network of over 550,000 agent locations across more than 200 countries and territories has offered in-minutes payout for many decades. And now Western Union customers have the choice of moving funds globally with speed, with the company’s expanded capability to send cross-border, cross-currency money transfers and payments real-time to 50 countries when paid into select banks and digital wallets. The expansion has been fast-tracked since the beginning of this year with the goal of assessing as many as 100 countries for real-time capabilities by the end of 2020. Western Union’s global network now includes more than four billion bank account and wallets.
Western Union’s expansion of digital pay-in and pay-out, a strategic pillar for years, has become an especially critical capability as people around the world continue sending money to their loved ones and making business payments during the COVID-19 pandemic. During the crisis, Western Union has focused on accelerating the expansion of its digital money transfer capabilities so more consumers and business can make essential cross-border payments and transfers from the safety of their homes.
Last month, Western Union announced the expansion of its digital money transfer services, the fastest-growing part of its business in 2019, to more than 75 countries. The Company’s digital services capture all the top 20 of the world’s primary remittance-sending countries ranked by the World Bank. Similarly, the Company’s global bank account and wallet payout network, along with in-minutes payout capability to select bank accounts and wallets, covers most of the world’s major remittance-receiving countries. Given the critical nature of money movement during the COVID-19 crisis, this end-to-end coverage assures that these reliable, convenient digital services are available to millions of the world’s most active money movers.
“Western Union is continuing to execute on its strategy by investing in and growing our global network to empower businesses and consumers to move money or make payments how they choose, to where they choose, as quickly as possible,” said Western Union President and CEO Hikmet Ersek. “The COVID-19 crisis has strengthened our commitment to be a reliable partner for people and enterprises to move funds globally in real-time.”
Ersek said, “This is a prime example of how the expanding global reach, interconnectedness and speed of Western Union’s global network generates customer benefits that are difficult to match. Our unique platform cuts through international complexities so customers can access their funds in real-time in more and more places. As we expand from our roots in consumer remittances, we’re positioning ourselves as the platform of choice for next-generation payments businesses and financial institutions and their diverse cross-border payments needs.”
Western Union’s consumer-to-consumer money in-minutes cross-border payments capability is now active when sending to select banks or digital wallet providers in 50 countries: Austria, Bangladesh, Bulgaria, Burundi, Cambodia, Cameroon, China, Costa Rica, Cyprus, Czech Republic, Democratic Republic of Congo (DRC), Denmark, Estonia, Ethiopia, Fiji, Finland, France, Ghana, Guatemala, India, Indonesia, Italy, Ivory Coast, Kenya, Latvia, Lithuania, Luxembourg, Malawi, Mexico, Mongolia, Mozambique, Nepal, Netherlands, Nigeria, Pakistan, Philippines, Portugal, Rwanda, Senegal, Spain, Sri Lanka, Sweden, Switzerland, Tanzania, Turkey, Uganda, Ukraine, United Arab Emirates, Zambia and Zimbabwe.
Accelerating Access to Cross-Border Transfers In-Minutes
The advancement of Western Union’s global cross-border, cross-currency money movement platform – including international real-time cross-border transfers, global settlement capabilities, network, compliance and technology systems — is positioning the company as the world’s foremost integrator of money movement and payments, globalizing services for its own customers as well for financial institutions and other payment providers.
In addition to its expansive digital footprint and settlement and compliance infrastructure, Western Union boasts a global retail network with in-minutes payout to more than 550,000 agent locations across more than 200 countries and territories.
Western Union’s recently announced open-platform strategy is allowing the company to innovatively connect the digital and physical worlds of money while helping leading organizations scale their services globally. The company offers banks and other payment providers a portfolio of application programming interfaces (APIs) to integrate with its cross-border, cross-current money movement platform with the added benefit of Western Union’s treasury management, reconciliation, and global compliance capabilities.
WU-G
About Western Union
The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Our omnichannel platform connects the digital and physical worlds and makes it possible for consumers and businesses to send and receive money and make payments with speed, ease, and reliability. As of December 31, 2019, our network included over 550,000 retail agent locations offering our branded services in more than 200 countries and territories, with the capability to send money to billions of accounts. Additionally, westernunion.com, our fastest growing channel in 2019, is available in over 75 countries, plus additional territories, to move money around the world. With our global reach, Western Union moves money for better, connecting family, friends, and businesses to enable financial inclusion and support economic growth. For more information, visit www.westernunion.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200423005498/en/
Contact information
Media Contacts:
Western Union Global Communications
Pia De Lima; Pia.DeLima@westernunion.com
+1 (954) 260-5732
Western Union Americas
Margaret Fogarty; maragaret.fogarty@wu.com
Western Union Middle East & Africa
Mohamed El Khalouki; Mohamed.ElKhalouki@wu.com
Western Union Asia-Pacific
Karen Santos; Karen.Santos2@westernunion.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
